FDA approves UroGen’s Zusduri to treat recurrent bladder cancer

17th June 2025 Uncategorised 0

Approximately 59,000 LG-IR-NMIBC patients experience recurrent disease every year in the US

More: FDA approves UroGen’s Zusduri to treat recurrent bladder cancer
Source: News